{"chunk_id": "medquad__chunk_6156", "source": "medquad", "text": "bitor therapy is being studied for the treatment of patients with triple negative breast cancer or tumors with  BRCA1  or  BRCA2  mutations.    See Drugs Approved for Breast Cancer for more information.\n                \n                \n                    New types of treatment are being tested in clinical trials.\n                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinic"}